Cargando…
Metformin use and cervical cancer risk in female patients with type 2 diabetes
This study evaluated whether metformin may affect the risk of cervical cancer. The reimbursement databases of the Taiwan's National Health Insurance were used. Female patients with type 2 diabetes at an onset age of 25-74 years during 1999-2005 and newly treated with metformin (n=132971, “ever...
Autor principal: | Tseng, Chin-Hsiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312330/ https://www.ncbi.nlm.nih.gov/pubmed/27486978 http://dx.doi.org/10.18632/oncotarget.10934 |
Ejemplares similares
-
Metformin and lung cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2017) -
Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016) -
Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016) -
Metformin may reduce oral cancer risk in patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2015) -
Metformin use is associated with a lower risk of uterine leiomyoma in
female type 2 diabetes patients
por: Tseng, Chin-Hsiao
Publicado: (2019)